|
|
 |
PRESS RELEASE:
Millions of
Dollars Redirected HepCop
has publicly denounced the National Institutes of Health (NIH) for
spending millions of dollars budgeted for Hepatitis C
(HCV) on other research agendas. |
National
Cancer Institute
NCI Grants
|
|
Description |
Project Number |
Researcher |
Cost |
Project Title |
|
$795,961 |
HBV/Viral
Hep Study |
5P01CA123328-02 |
TAVIS, JOHN |
$469,011 |
Mechanism of viral hepatitis-mediated
hepatocarcinogenesis |
|
|
|
5P01CA123328-02 |
WEISS, JEFFREY |
$326,950 |
HEPATIC CARCINOGENESIS INDUCED BY HEPATITIS B VIRUS
PreS2 MUTANT |
|
$4,381,175 |
HCC Study |
5R01CA122499-02 |
JACOBSON, KENNETH |
$266,000 |
Oxidative Stress and Hepatocellular Carcinoma |
|
|
|
1R01CA126807-01A1 |
JERNIGAN, TERRY |
$274,523 |
Role of metallothioneins in hepatocellular carcinoma |
|
|
|
5R21CA122523-02 |
MEHTA, ANAND |
$150,000 |
HCC diagnostics defined by fucosylated serum
biomarkers |
|
|
|
2R42CA121506-02 |
LINDSAY, KAREN |
$564,986 |
Hepatocellular carcinoma: targeting HCV replication |
|
|
|
5K01CA107092-05 |
BROWN, KAREN |
$162,378 |
Randomized trial of doxorubicin beads for arterial
embolization of hepatocellular |
|
|
|
5R21CA128391-02 |
BUCK, MARTINA |
$187,000 |
HEPATOCELLULAR CARCINOMA AND HEPATITIS C: E2
MOLECULAR MECHANISMS |
|
|
|
1K22CA128866-01A1 |
TARAKHOVSKY, ALEXANDER |
$148,770 |
Biomarker for Hepatocellular Carcinoma |
|
|
|
5R01CA125487-02 |
SNYDER, NED |
$291,650 |
HCV genetic variation and hepatocellular carcinoma |
|
|
|
1R01CA127481-01A2 |
EMERSON, SUZANNE |
$293,416 |
Surveillance for Hepatocellular Carcinoma among
HCV-infected Veterans |
|
|
|
1R21CA133266-01A1 |
DAVID, MICHAEL |
$200,550 |
Hepatocarcinogenesis Secondary to Hepatitis C |
|
|
|
5P01CA123328-02 |
SU, LISHAN |
$272,798 |
Development of 3D Differentiated Hepatocyte Culture
Systems for the Study of HCC |
|
|
|
1Z01BC010893-01 |
LAU, DARYL |
$270,744 |
Role of Inflammation and DNA Damage-Repair in HCV
Carcinogenesis |
|
|
|
1Z01CP005782-14 |
VLAHAKIS, STACEY |
$1,060,598 |
Tumor models for the study of inflammation and
oncogenesis |
|
|
|
5R01CA123544-02 |
O'BRIEN, CHARLES |
$237,762 |
Epidemiology of Oncogenic Viruses |
|
$578,686 |
HCV Based Study |
5R01CA123544-02 |
KRATTIGER, ANATOLE |
$126,357 |
Hepatitis C Virus Replication and Intracellular
Membrane Rearrangement |
|
|
|
5R01CA085888-09 |
LUO, GUANGXIANG |
$297,351 |
Malignant Complications of Chronic HCV |
|
|
|
5K22CA129241-02 |
SCHOGGINS, JOHN |
$154,978 |
Biomarker Discovery for Hepatitis C Progression
using Machine Learning Techniques |
|
$168,000 |
HIV/HCV Study |
1R41CA132397-01 |
DI BISCEGLIE, ADRIAN |
$168,000 |
Small Molecule Inhibitors of HBV/HCV Induced Liver
Diseases |
|
$167,868 |
Interferon/Antivial Treatment HCV Study |
3R21CA125321-02S1 |
SNYDER, NED |
$20,868 |
Variation in NTP use by the HCV polymerase and
response to therapy |
|
|
|
5R21CA125321-02 |
SNYDER, NED |
$147,000 |
Variation in NTP use by the HCV polymerase and
response to therapy |
|
$118,806 |
Liver Disease Study |
5K07CA106458-04 |
HE, JOHNNY |
$118,806 |
Molecular Epidemiology of Chronic Liver Diseases |
|
$1,222,206 |
Lymphoma HCV Studies |
1Z01CP010170-08 |
HAYASHI, PAUL |
$1,222,206 |
Multidisciplinary Studies of Lymphoma |
|
$123,133 |
Unknown |
1Z01BC005800-14 |
RYAN, ELIZABETH |
$123,133 |
Discovering Disease Susceptibility Genes in African
Americans
|
|
|
|
|
Total NIC Funding |
$7,555,835 |
|
Source: National Institutes of Health Research Portfolio
Online Reporting Tool (RePORT) Reports,
Data and Analyses of NIH Research Activities
Retrieved on March 18, 2009
http://report.nih.gov/rcdc/categories/ProjectSearch.aspx?FY=2008&DCat=Hepatitis+-+C
Permission is granted to use all information from this website
in pursuit of ending NIH's "Trans-Plan" discriminatory practices against HCV
research funding allocations.
Please Credit: HCVets.com Educational Website &
Support Forums for Military Related HCV Exposures.
Contact HepCop
Email:
Staff
|
